Cardiovascular risk factors in HIV-infected patients

Andrew Carr1

  • 1HIV Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital, Sydney, 2010, Australia. acarr@stvincents.com.au

Insights

Highly active antiretroviral therapy (HAART) can cause dyslipidemia and insulin resistance, increasing cardiovascular disease (CVD) risk. Treatment strategies for these conditions are unclear, especially for patients with lower HIV progression risk.

Area of Science:

  • Internal Medicine
  • Cardiology
  • Infectious Diseases

Background:

  • Highly active antiretroviral therapy (HAART) is associated with persistent dyslipidemia and insulin resistance.
  • These metabolic changes are suspected to increase the incidence of cardiovascular disease (CVD) in patients on HAART.
  • Both protease inhibitors (PIs) and nucleoside analog reverse transcriptase inhibitors (NRTIs) contribute to these adverse effects.

Purpose of the Study:

  • To review the relationship between HAART, dyslipidemia, insulin resistance, and cardiovascular disease (CVD).
  • To evaluate the current treatment strategies for managing dyslipidemia and insulin resistance in patients on HAART.
  • To clarify the safety, efficacy, and optimal roles of various treatment interventions.

Main Methods:

  • Review of existing literature on HAART, metabolic complications, and CVD.
  • Analysis of studies investigating the impact of PIs and NRTIs on lipid and glucose metabolism.
  • Evaluation of treatment strategies including lifestyle changes, pharmacotherapy, and antiretroviral regimen modification.

Main Results:

  • HAART-induced dyslipidemia and insulin resistance are linked to increased CVD risk.
  • PIs have direct metabolic effects, while both PIs and NRTIs contribute indirectly via lipodystrophy.
  • Previous studies on CVD incidence and HAART lacked prospective design and adequate power.
  • The relative safety and efficacy of management strategies for dyslipidemia and insulin resistance remain unclear.

Conclusions:

  • Management of dyslipidemia and insulin resistance is recommended for HAART patients, particularly those with multiple CVD risk factors.
  • Treatment benefits are greatest in individuals with higher perceived CVD risk and lower risk of HIV disease progression.
  • Further prospective studies are needed to establish definitive treatment guidelines and assess long-term outcomes.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...